key points in differential diagnosis in myasthenic syndromes

Detalhes bibliográficos
Autor(a) principal: Machado, S
Data de Publicação: 2013
Outros Autores: Pires, C, Manji, H
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/1489
Resumo: Neuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized.
id RCAP_d9de3850a14f204d00b85347127afc83
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1489
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling key points in differential diagnosis in myasthenic syndromesAspectos fundamentais do diagnóstico diferencial dos sindromas miasténicosCongenital myasthenic syndromesMyasthenia gravisDifferential diagnosisSíndromes miasténicos congénitosMiastenia gravisDiagnóstico diferencialNeuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized.Sociedade Portuguesa de NeurologiaRepositório do Hospital Prof. Doutor Fernando FonsecaMachado, SPires, CManji, H2015-08-17T10:04:37Z2013-01-01T00:00:00Z2013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/1489engSinapse. 2013 Maio;13(1):15-221645-281Xinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:52:15Zoai:repositorio.hff.min-saude.pt:10400.10/1489Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:52:32.837219Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv key points in differential diagnosis in myasthenic syndromes
Aspectos fundamentais do diagnóstico diferencial dos sindromas miasténicos
title key points in differential diagnosis in myasthenic syndromes
spellingShingle key points in differential diagnosis in myasthenic syndromes
Machado, S
Congenital myasthenic syndromes
Myasthenia gravis
Differential diagnosis
Síndromes miasténicos congénitos
Miastenia gravis
Diagnóstico diferencial
title_short key points in differential diagnosis in myasthenic syndromes
title_full key points in differential diagnosis in myasthenic syndromes
title_fullStr key points in differential diagnosis in myasthenic syndromes
title_full_unstemmed key points in differential diagnosis in myasthenic syndromes
title_sort key points in differential diagnosis in myasthenic syndromes
author Machado, S
author_facet Machado, S
Pires, C
Manji, H
author_role author
author2 Pires, C
Manji, H
author2_role author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Machado, S
Pires, C
Manji, H
dc.subject.por.fl_str_mv Congenital myasthenic syndromes
Myasthenia gravis
Differential diagnosis
Síndromes miasténicos congénitos
Miastenia gravis
Diagnóstico diferencial
topic Congenital myasthenic syndromes
Myasthenia gravis
Differential diagnosis
Síndromes miasténicos congénitos
Miastenia gravis
Diagnóstico diferencial
description Neuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01T00:00:00Z
2013-01-01T00:00:00Z
2015-08-17T10:04:37Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/1489
url http://hdl.handle.net/10400.10/1489
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Sinapse. 2013 Maio;13(1):15-22
1645-281X
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Neurologia
publisher.none.fl_str_mv Sociedade Portuguesa de Neurologia
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130391489019904